Compass Financial Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$340 Hold
2025
Q1
$238 Hold
2024
Q4
$276 Buy